MIR503HG and non-small cell lung carcinoma: Conversely, in anaplastic lymphoma kinase-negative anaplastic large cell-lymphoma (ALK-negative ALCL) and non-small cell lung cancer MIR503HG is upregulated and mediates tumor-promoting effects [56, 57].